Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00151281
What this trial is testing

Phase II Study of RT-PEPC in Relapsed Mantle Cell Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Weill Medical College of Cornell University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Testing effectiveness (Phase 2)Study completedNCT00578526
What this trial is testing

SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial

Who this might be right for
Urothelial CancerBladder CancerAdult
AHS Cancer Control Alberta 64
Not applicableEnded earlyNCT02423785
What this trial is testing

Ocular Blood Flow in Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Medical University of Vienna 11
Testing effectiveness (Phase 2)UnknownNCT05341193
What this trial is testing

PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 32
Testing effectiveness (Phase 2)WithdrawnNCT01633255
What this trial is testing

[18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment

Who this might be right for
Kidney Neoplasms
National Cancer Institute (NCI)
Not applicableUnknownNCT03732235
What this trial is testing

TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer

Who this might be right for
Liver Metastasis Colon Cancer
Giammaria Fiorentini 50
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Testing effectiveness (Phase 2)Looking for participantsNCT06728852
What this trial is testing

Efficacy and Safety of Vorolanib Monotherapy As Third-line or Later Treatment for Advanced Non-small Cell Lung Cancer Patients: a Single-arm, Prospective, Open-label Phase II Clinical Study

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)Recurrent or Metastatic Lung CancerThird-line and Beyond Therapy+1 more
Li-kun Chen 32
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Testing effectiveness (Phase 2)WithdrawnNCT01225510
What this trial is testing

A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Pfizer
Early research (Phase 1)Study completedNCT00807859
What this trial is testing

Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsBreast Tumors+7 more
Amgen 65
Large-scale testing (Phase 3)Study completedNCT00866697
What this trial is testing

Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 940
Testing effectiveness (Phase 2)Study completedNCT00094107
What this trial is testing

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
Pfizer 32
Testing effectiveness (Phase 2)Study completedNCT00083408
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 20
Testing effectiveness (Phase 2)Study completedNCT03126331
What this trial is testing

Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab

Who this might be right for
Metastatic Renal Cell Carcinoma
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00304525
What this trial is testing

Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Novartis Pharmaceuticals 104
Testing effectiveness (Phase 2)Study completedNCT01079780
What this trial is testing

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 136
Testing effectiveness (Phase 2)Looking for participantsNCT06482801
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Who this might be right for
Liver CancerAntibody
Second Affiliated Hospital of Guangzhou Medical University 90
Early research (Phase 1)UnknownNCT05273814
What this trial is testing

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Next Page